Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

scientific article published in October 1989

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(89)91016-7
P698PubMed publication ID2572740

P50authorMichael HoughtonQ1927895
P2093author name stringM Colombo
G Kuo
Q L Choo
E Del Ninno
M F Donato
N Dioguardi
M A Tommasini
P2860cites workIsolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genomeQ27860719
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitisQ27860909
NIH conference. Hepatocellular carcinomaQ38184652
Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.Q39502500
Cirrhosis and the aetiology of hepatocellular carcinomaQ39508676
Relationship between hepatocellular carcinoma and cirrhosisQ40077062
Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcoholQ45841358
Hepatitis C virus antibodies among risk groups in SpainQ45844599
Risk factors for hepatocellular carcinoma in Northern ItalyQ57562717
Viral superinfectionQ69722780
A multicenter, prospective study of posttransfusion hepatitis in MilanQ70349298
Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitisQ72400334
Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitisQ72711744
P433issue8670
P407language of work or nameEnglishQ1860
P921main subjectItalyQ38
antibodyQ79460
hepatitis CQ154869
patientQ181600
Hepatitis C virusQ708693
P304page(s)1006-1008
P577publication date1989-10-01
P1433published inThe LancetQ939416
P1476titlePrevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
P478volume2

Reverse relations

cites work (P2860)
Q53347425A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients.
Q45210037A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
Q42988527A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus
Q39385948A retrospective study of hepatitis C virus carriers in a local endemic town in Japan. A possible presence of asymptomatic carrier
Q42632605A structural protein encoded by the 5' region of the hepatitis C virus genome efficiently detects viral infection
Q42985662A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus
Q45770049Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Q91729031Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation
Q53460729Alcohol, hepatotropic viruses, and hepatocellular carcinoma.
Q50994209Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
Q36033548Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development
Q42981000Alteration of DNA ploidy and cell nuclearity in human hepatocellular carcinoma associated with HBV infection
Q39813695An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 1. Validity of the Chimpanzee Model
Q41852597Androgen associated hepatocellular carcinoma with an aggressive course.
Q42982556Anti-HCV antibodies and hepatocellular carcinoma. Relationship in a medium-risk population
Q43048217Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon
Q43753998Antibodies to hepatitis C virus in patients undergoing hemodialysis in Salvador, BA, Brazil
Q37534731Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
Q42981246Anti‐HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: Relation to multitransfusion
Q33617717Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population
Q77908531B and C hepatitis viruses, HLA-DQ1 and -DR3 alleles and autoimmunity in patients with hepatocellular carcinoma
Q38012691Cancer and viruses: a double-edged sword
Q38466366Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study
Q50849790Characteristics of hepatocellular carcinoma in Italy.
Q27486074Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
Q42981306Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells
Q27486027Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites
Q42980768Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A.
Q30431528Chronic hepatitis C: the virus, its discovery and the natural history of the disease
Q35236549Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan
Q42980763Clinical evaluation of a newly established anti‐HCV assay for the diagnosis of hepatitis C in Japan
Q27477946Clinical guidelines on the management of hepatitis C
Q58033435Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma
Q35233963Clinical spectrum of viral infections in hemophilic patients
Q45392678Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma
Q42991523Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma
Q45730394Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients
Q45852327Correlation of hepatitis C virus antibodies with HIV-1 seropositivity in intravenous drug addicts
Q45361548Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
Q36496830Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy
Q43040424Demonstration of HCV-RNA and HBV-DNA in the serum of HBsAg negative patients with hepatocellular carcinoma
Q43038220Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma tissues
Q43048952Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients
Q27485151Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients
Q27488101Detection of hepatitis C virus sequences in sera with controversial serology by nested polymerase chain reaction
Q27478449Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma
Q43048410Development of a specific enzyme-linked immunosorbent assay for the hepatitis C virus antibody using clone 14.
Q42981934Development of antibody to hepatitis C virus (HCV) in acute and chronic non-A, non-B post-transfusion hepatitis
Q50579359Development of hepatocellular carcinoma after interferon therapy in chronic hepatitis C. Is it possible to reduce the incidence by ribanirin and IFN combination therapy?
Q67486488Development of hepatocellular carcinoma in a man with auto‐immune chronic active hepatitis
Q45363707Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy.
Q56561242Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma
Q79823799Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening
Q51090924Dilemma of the natural history of hepatitis C.
Q24653498Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor
Q33407730Discovery of the hepatitis C virus
Q27488868Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome
Q40850644Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients
Q34683615Does hepatitis C virus cause severe liver disease only in people who drink alcohol?
Q44012761Does hepatitis C virus infection contribute to hepatocellular carcinoma in hong kong?
Q52909973Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.
Q43450451Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.
Q55094662Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.
Q33972219Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples
Q45367944Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus.
Q45783851Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study
Q43031055Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone
Q27473016Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA
Q73451716Efficacy of prophylactic sclerotherapy in patients with hepatocellular carcinoma and varices negative for the red color sign
Q28484539Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats
Q37906017Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends
Q36447914Epidemiology of hepatitis C virus in Japan: role in chronic liver disease and hepatocellular carcinoma
Q70756324Epidemiology of hepatitis C virus infection
Q45704455Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow up.
Q27469317Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma
Q73549886Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan)
Q27486022Expression and identification of hepatitis C virus polyprotein cleavage products
Q58862457Expression of thec-myc protooncogene product in cells infected with the hepatitis delta virus
Q24563988Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma
Q72855674Follow-up study of acute hepatitis C
Q42988155Frequent detection of hepatitis C virus US strain in Japanese hemophiliacs
Q44236813GSTT1 null genotype contributes to hepatocellular carcinoma risk: a meta-analysis
Q43048277Genotypic subtyping of hepatitis C virus
Q37903326Geographic heterogeneity of hepatocellular carcinoma.
Q39381895Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology).
Q40172999Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C.
Q41818102HBV & HCV - awareness in acute abdomen emergency cases
Q42981930HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease
Q72048519HCV infection and hepatocellular carcinoma in cirrhotics: what is the linkage?
Q43039277HCV infection in alcoholics.
Q42982244HCV infection in symptom-free patients
Q42985994HCV infection, hepatic HLA display and composition of the mononuclear cell inflammatory infiltrate in chronic alcoholic liver disease
Q42996927HCV seroreactivity and detection of HCV RNA in cirrhotics
Q42978297HCV-associated hepatocellular carcinoma without cirrhosis
Q40818830HVR1 quasispecies analysis from a long-term culture of hepatitis C virus in Hep G2 derived cells grown in a haemodialysis cartridge
Q42983276Hepatitis B and C viral infections in patients with hepatocellular carcinoma
Q43038729Hepatitis B virus DNA in serum and liver is commonly found in chinese patients with chronic liver disease despite the presence of antibodies to HBsAg
Q35231554Hepatitis B virus infection and primary hepatocellular carcinoma
Q42980930Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma
Q33929132Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management
Q42978560Hepatitis C biochemical remission and viral replication in haemodialysis patients
Q55241882Hepatitis C in deceased drug addicts.
Q43047908Hepatitis C infection in children and adolescents on haemodialysis and after renal transplant
Q42984610Hepatitis C infection in renal transplant recipients in Israel
Q35960912Hepatitis C infection in transplantation
Q43037190Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia
Q77720263Hepatitis C virus NS3/4A protease
Q42986534Hepatitis C virus RNA genome in plasma of patients with non-A, non-B hepatitis
Q43036983Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects.
Q36135489Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma
Q28283484Hepatitis C virus and hepatocarcinogenesis
Q73235881Hepatitis C virus and hepatocellular carcinoma
Q45858814Hepatitis C virus and hepatocellular carcinoma in France: detection of antibodies using two second generation assays
Q35891695Hepatitis C virus and lichen planus
Q37887627Hepatitis C virus and transfusion transmitted liver disease: review
Q39243681Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
Q43036518Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients
Q43048361Hepatitis C virus associated primary hepatocellular carcinoma in a noncirrhotic liver
Q27480393Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
Q42983445Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
Q37362701Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis
Q27490250Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience
Q42980514Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand
Q43047220Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease
Q47555610Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature
Q34144211Hepatitis C virus infection and risk of cancer: a population-based cohort study
Q26829202Hepatitis C virus infection and type 1 and type 2 diabetes mellitus
Q43863350Hepatitis C virus infection in African patients with liver cirrhosis or primary hepatocellular carcinoma
Q45775194Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma
Q42981412Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia
Q41398433Hepatitis C virus infection in dialysis and renal transplantation
Q42984545Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis
Q44114739Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis
Q45875781Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.
Q41225114Hepatitis C virus infection: clinical aspects and treatment with interferon alfa
Q39655346Hepatitis C virus replication in hepatocellular carcinoma
Q27469295Hepatitis C virus. A review
Q68477913Hepatitis C-associated hepatocellular carcinoma
Q40404044Hepatitis C-related chronic liver disease among asymptomatic blood donors in the north west of England
Q33339419Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation
Q71702111Hepatitis C: diagnosis and treatment
Q42987946Hepatitis C: from laboratory to bedside
Q35233238Hepatitis C: virology, epidemiology, clinical course, and treatment
Q42042952Hepatitis type C virus infection in patients with type B chronic liver disease
Q34528514Hepatocellular carcinoma and hepatitis C in the United States
Q36401904Hepatocellular carcinoma. A worldwide problem and the major risk factors
Q27489394Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Q35227361Hepatocellular carcinoma: Recent progress
Q27486176Hepatology
Q43035375High level of hepatitis C endemicity in Gabon, equatorial Africa
Q43039375High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma
Q45881200High prevalence of hepatitis C virus infection in aborigines in Taiwan
Q43037723High proportion of false positive reactions among donors with anti‐HCV antibodies in a low prevalence area
Q35939195Histologic Study of Chronic Active Hepatitis C: Comparison with Chronic Active Hepatitis B
Q26767036Historical review of the causes of cancer
Q43576596Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.
Q34614394Human tumor-associated viruses and new insights into the molecular mechanisms of cancer
Q42982497Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues
Q27480600IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C
Q45789715Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second‐generation anti‐hepatitis C virus assay
Q42989419In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions
Q33906429Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis
Q41141514Induction of apoptosis in a human hepatocellular carcinoma cell line by a neutralizing antibody to transforming growth factor-alpha
Q35489328Infection and cancer: current state of art
Q34538006Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: a case-control study. Provincial Group for the Study of Chronic Liver Disease
Q40937852Interactions between alcohol and hepatitis viruses in the liver.
Q60211106Interferon for chronic hepatitis C in patients cured of malignancy
Q42987918Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus
Q42984591Intrafamilial transmission of hepatitis C.
Q44181005Irregularity of parenchymal echo patterns of liver analyzed with a neural network and risk of hepatocellular carcinoma in liver cirrhosis
Q24648164Kinetic and structural analyses of hepatitis C virus polyprotein processing
Q42980799Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis
Q43409999Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study
Q72421238Liver disease
Q43753027Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
Q45737371Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study
Q43595642Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group
Q45858833Long-term persistence of hepatitis C virus antibodies in a single source outbreak
Q74530378Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression
Q45858875Low prevalence of hepatitis C virus and infrequent perinatal or spouse infections in pregnant women in Taiwan
Q43035439Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trial
Q34798261Lymphoblastoid interferon alfa treatment in chronic hepatitis C
Q45886289Management of chronic hepatitis C.
Q27477721Managing chronic hepatitis C virus infection
Q35092460Mechanisms of alcohol-induced tissue injury
Q30468280Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?
Q35832747Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation
Q36469423Molecuar biology of hepatocellular carcinoma and hepatitis B virus association
Q36441749Molecular biology of non-A, non-B hepatitis agents: hepatitis C and hepatitis E viruses
Q27860811Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
Q37858630Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection
Q42998892Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality
Q43035596Mooren-type hepatitis C virus-associated corneal ulceration.
Q45767597Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis
Q33809420Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma
Q26749329New advances in hepatocellular carcinoma
Q42105512New antiviral agents for hepatitis C
Q27469293Non-A, non-B hepatitis
Q45857078Non-parenteral transmission of hepatitis C virus
Q44444276Occupational risk for hepatitis C virus infection among New York City dentists
Q53579868Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease.
Q42050840Oval cell numbers in human chronic liver diseases are directly related to disease severity.
Q52139868Parenchymal echo patterns of cirrhotic liver analysed with a neural network for risk of hepatocellular carcinoma.
Q41332812Patterns of progression: unpredictability and risk of decompensated cirrhosis
Q62658386Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg-Negative Patients: A Study of a Low-endemic Area
Q33818746Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial
Q45749872Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus
Q43749890Practical approach to the discovery of a positive HCV serology in a blood donor
Q44511056Presence of anti-hepatitis C virus serum markers in a dental school patient population
Q43671045Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL.
Q42986046Prevalence and significance of antibodies to hepatitis c virus among Saudi haemodialysis patients
Q35939128Prevalence of Antibodies to Hepatitis C Virus in Patients with Various Types of Liver Diseases
Q42988143Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections
Q42980969Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis
Q43035800Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease
Q45789661Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease
Q45871217Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria
Q45850898Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma
Q42985722Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma
Q43034959Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea
Q42981825Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India
Q27485927Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini
Q62607309Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis
Q34508847Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region
Q27487881Quantitation of hepatitis C virus genome molecules in plasma samples
Q53460454Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
Q43048173Relation of hepatitis C virus to hepatocellular carcinoma
Q45764849Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.
Q43039289Relevance of anti-HCV reactivity in patients with alcoholic hepatitis. VA cooperative Study Group #275.
Q77221798Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis
Q36684658Review of hepatitis C in Japan
Q43049218Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon
Q42980410Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
Q51872438Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.
Q72082159Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Q26775650Risk Factors for the Development of Hepatocellular Carcinoma in Thailand
Q50619400Risk factors and prevention of hepatocellular carcinoma in HCV infection.
Q43330713Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy
Q57763153Risk of Hepatocellular Carcinoma Development in Cases of Hepatitis C Treated by Long-Term, Low-Dose PEG-IFNa-2a
Q79294727Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma
Q42981016Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: A 5-Year prospective study
Q55130799Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma.
Q74027220Screening for hepatocellular carcinoma
Q84921251Screening for hepatocellular carcinoma
Q71684510Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein
Q43048384Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay
Q37519291Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus
Q42983311Seropositivity to hepatitis C virus (HCV) in Saudi children with chronic renal failure maintained on haemodialysis
Q79299908Seroprevalence and outcome of hepatitis C in liver transplantation
Q44684456Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis
Q50565830Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C.
Q33640766Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
Q27477689Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV
Q44488142Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis
Q41302293Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides
Q46514306Strenuous physical labor is important as a cause of elevated alanine aminotransferase levels in Japanese patients with chronic hepatitis C viremia
Q27478443Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase
Q27486067Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells
Q67486992Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis
Q34609714Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol
Q43000578Sustained viral response prolonged survival of patients with C-viral hepatocellular carcinoma
Q42984313Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.
Q58802894T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections
Q64069871The association of liver function and quality of life of patients with liver cancer
Q36409001The detection of hepatitis B virus (HBV) in HBsAG negative individuals with primary liver cancer
Q54759655The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma.
Q37576273The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis
Q24610004The history of tumor virology
Q72085589The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men
Q41098848The molecular pathogenesis of hepatocellular carcinoma.
Q35960890The natural history of chronic hepatitis C virus infection
Q35035439The natural history of hepatocellular carcinoma.
Q39418450The oncologic burden of hepatitis C virus infection: A clinical perspective.
Q45853309The polymerase chain reaction for hepatitis B virus DNA.
Q45178683The prevalence of anti-hepatitis C virus among chinese patients with hepatocellular carcinoma
Q33394200The prevalence of antibody to hepatitis C virus (anti-HCV) in patients with acute and chronic liver diseases in Jakarta, Indonesia
Q45854272The prevalence of hepatitis C virus antibody in high risk group of Thai children and adults
Q42981043The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study
Q43039226The role of hepatitis C virus in chronic hepatitis B virus infection
Q45786134The sexual transmission of hepatitis C virus
Q42988133The significance of anti-hepatitis C virus antibodies measured in chronic liver disease
Q35747461Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin
Q42988100Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma
Q57951603Tropical medicine
Q44454738Type C viral hepatitis
Q35581216Ultrastructural alterations and expression of cytoplasmic antigen 48-1 in hepatocytes in association with hepatitis C virus infection
Q43036129Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma
Q33894872View and review on viral oncology research
Q68008537Viral hepatitis
Q21245597Viral hepatitis and hepatocellular carcinoma
Q72749710[Hepatitis C]

Search more.